CPHI vs IRM · rev $4.1M vs P/E 136, rev $6.15B
China Pharma Holdings Inc (CPHI) versus Iron Mountain Incorporated (IRM) — a side-by-side from cached financials, not a winner call.
China Pharma Holdings Inc (CPHI) is a drug manufacturers - specialty & generic company listed on US.
Iron Mountain Incorporated (IRM) is a reit - specialty company listed on US.
Latest reported CPHI revenue for 2025-12-31 was $4.1M. Net income was -$3.2M. Revenue was down 8.5% from 2024-12-31 to 2025-12-31. CPHI currently screens at market cap $29.0M.
Latest reported IRM revenue for 2024-12-31 was $6.15B. Net income was $183.7M. Revenue was up 12.2% from 2023-12-31 to 2024-12-31. IRM currently screens at market cap $37.09B and trailing P/E 135.5.
CPHI currently screens at market cap $29.0M. IRM currently screens at market cap $37.09B and trailing P/E 135.5.
Not investment advice. Open the CPHI and IRM stock pages for the full models.
Not investment advice.